Daré Bioscience (DARE) Competitors $2.71 -0.27 (-9.06%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends DARE vs. CRDL, DERM, ANRO, IMUX, IPSC, SKYE, AVTX, MNOV, CNTX, and PYXSShould you be buying Daré Bioscience stock or one of its competitors? The main competitors of Daré Bioscience include Cardiol Therapeutics (CRDL), Journey Medical (DERM), Alto Neuroscience (ANRO), Immunic (IMUX), Century Therapeutics (IPSC), Skye Bioscience (SKYE), Avalo Therapeutics (AVTX), MediciNova (MNOV), Context Therapeutics (CNTX), and Pyxis Oncology (PYXS). These companies are all part of the "pharmaceutical products" industry. Daré Bioscience vs. Cardiol Therapeutics Journey Medical Alto Neuroscience Immunic Century Therapeutics Skye Bioscience Avalo Therapeutics MediciNova Context Therapeutics Pyxis Oncology Daré Bioscience (NASDAQ:DARE) and Cardiol Therapeutics (NASDAQ:CRDL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, community ranking, media sentiment, valuation, profitability and risk. Does the MarketBeat Community prefer DARE or CRDL? Daré Bioscience received 333 more outperform votes than Cardiol Therapeutics when rated by MarketBeat users. Likewise, 73.31% of users gave Daré Bioscience an outperform vote while only 63.16% of users gave Cardiol Therapeutics an outperform vote. CompanyUnderperformOutperformDaré BioscienceOutperform Votes35773.31% Underperform Votes13026.69% Cardiol TherapeuticsOutperform Votes2463.16% Underperform Votes1436.84% Which has more volatility & risk, DARE or CRDL? Daré Bioscience has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Does the media prefer DARE or CRDL? In the previous week, Cardiol Therapeutics had 3 more articles in the media than Daré Bioscience. MarketBeat recorded 6 mentions for Cardiol Therapeutics and 3 mentions for Daré Bioscience. Cardiol Therapeutics' average media sentiment score of 0.69 beat Daré Bioscience's score of 0.01 indicating that Cardiol Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daré Bioscience 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cardiol Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, DARE or CRDL? Cardiol Therapeutics has lower revenue, but higher earnings than Daré Bioscience. Daré Bioscience is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaré Bioscience$1.88M12.53-$30.16M-$0.59-4.59Cardiol Therapeutics$60K1,743.00-$20.84M-$0.39-3.28 Do analysts rate DARE or CRDL? Daré Bioscience currently has a consensus price target of $24.00, suggesting a potential upside of 785.61%. Cardiol Therapeutics has a consensus price target of $8.75, suggesting a potential upside of 583.59%. Given Daré Bioscience's higher probable upside, analysts plainly believe Daré Bioscience is more favorable than Cardiol Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daré Bioscience 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Cardiol Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is DARE or CRDL more profitable? Cardiol Therapeutics has a net margin of 0.00% compared to Daré Bioscience's net margin of -191.65%. Daré Bioscience's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Daré Bioscience-191.65% N/A -18.98% Cardiol Therapeutics N/A -194.40%-129.07% Do insiders & institutionals believe in DARE or CRDL? 6.7% of Daré Bioscience shares are owned by institutional investors. Comparatively, 12.5% of Cardiol Therapeutics shares are owned by institutional investors. 4.0% of Daré Bioscience shares are owned by company insiders. Comparatively, 5.3% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryCardiol Therapeutics beats Daré Bioscience on 12 of the 19 factors compared between the two stocks. Ad Paradigm Press Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!Click here now for the urgent details. Get Daré Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DARE vs. The Competition Export to ExcelMetricDaré BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.58M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-4.5910.5990.0517.18Price / Sales12.53195.801,117.00116.99Price / CashN/A57.1642.9637.86Price / Book-4.445.094.784.78Net Income-$30.16M$151.83M$120.31M$225.60M7 Day Performance-14.78%-2.13%-1.92%-1.23%1 Month Performance-16.10%-3.10%11.50%3.36%1 Year Performance-28.35%11.54%30.59%16.60% Daré Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DAREDaré Bioscience1.5891 of 5 stars$2.71-9.1%$24.00+785.6%-31.1%$23.58M$1.88M-4.5930Analyst ForecastGap DownCRDLCardiol Therapeutics2.2534 of 5 stars$1.33-0.4%$8.75+560.4%+44.0%$108.26M$60,000.00-3.4120Analyst ForecastAnalyst RevisionNews CoverageGap DownDERMJourney Medical2.548 of 5 stars$5.00-1.8%$9.38+87.5%N/A$104.45M$79.18M-5.4190ANROAlto Neuroscience3.2563 of 5 stars$3.84+0.3%$20.00+420.8%N/A$103.57M$210,000.000.00N/AGap UpIMUXImmunic2.933 of 5 stars$1.15+1.3%$11.80+930.6%-20.6%$103.14MN/A-0.9270Positive NewsIPSCCentury Therapeutics1.8206 of 5 stars$1.21-0.8%$11.60+858.7%-52.6%$102.89M$2.68M-0.66170Gap DownHigh Trading VolumeSKYESkye Bioscience2.1878 of 5 stars$3.38+0.9%$18.67+452.3%-10.6%$102.54MN/A0.0011News CoveragePositive NewsGap DownAVTXAvalo Therapeutics3.7075 of 5 stars$9.82+6.4%N/A-13.7%$102.07M$820,000.000.0040Analyst ForecastNews CoverageMNOVMediciNova2.1642 of 5 stars$2.08-1.0%$9.00+332.7%+43.7%$102.02M$1M-9.9510Analyst ForecastPositive NewsCNTXContext Therapeutics2.9747 of 5 stars$1.36-2.2%$6.80+400.0%+1.0%$102.00MN/A-1.477Positive NewsGap DownPYXSPyxis Oncology2.1442 of 5 stars$1.67+3.1%$10.00+498.8%-2.9%$99.32MN/A-1.5760Analyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies Cardiol Therapeutics Alternatives Journey Medical Alternatives Alto Neuroscience Alternatives Immunic Alternatives Century Therapeutics Alternatives Skye Bioscience Alternatives Avalo Therapeutics Alternatives MediciNova Alternatives Context Therapeutics Alternatives Pyxis Oncology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DARE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Daré Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DARE Stock Alerts